Enabling Adoption of 2d-NMR for the Higher Order Structure Assessment of Monoclonal Antibody Therapeutics
mAbs - United States
doi 10.1080/19420862.2018.1544454
Full Text
Open PDFAbstract
Available in full text
Date
December 22, 2018
Authors
Publisher
Informa UK Limited